SERTRALINE CINFA 150 mg FILM-COATED TABLETS

Introduction

Package Leaflet: Information for theuser

Sertraline Cinfa 150mg film-coated tablets

Sertraline Cinfa 200 mg film-coated tablets

Sertraline hydrochloride

Read all of this leaflet carefully before you start taking thismedicine, because it contains important information for you.

• Keep this leaflet, as you may need to read it again.
• If you have any further questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
• If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

1. What is Sertraline Cinfa and what is it used for
2. What you need to know before you take Sertraline Cinfa
3. How to take Sertraline Cinfa
4. Possible side effects
5. Storage of Sertraline Cinfa
6. Contents of the pack and other information

1. What is Sertraline Cinfa and what is it used for

Sertraline Cinfa contains sertraline as the active substance. Sertraline belongs to a group of medicines called selective serotonin reuptake inhibitors (SSRIs); these medicines are used to treat depression and/or anxiety disorders.

Sertralinecan be used to treat:

• Depression and prevention of depression relapse (in adults).
• Social anxiety disorder (in adults).
• Post-traumatic stress disorder (PTSD) (in adults).
• Panic disorder (in adults).
• Obsessive-compulsive disorder (OCD) (in adults and in children and adolescents aged 6-17 years).

Depression is a clinical condition with symptoms such as feelings of sadness, inability to sleep well or to enjoy life as you used to.

OCD and anxiety disorders are conditions related to anxiety, with symptoms such as being constantly worried about recurring ideas (obsessions) that lead to performing repetitive rituals (compulsions).

PTSD is a disorder that can occur after a highly traumatic emotional experience, and has some symptoms similar to depression and anxiety. Social anxiety disorder (social phobia) is an anxiety-related condition. It is characterized by feeling intense anxiety or panic in social situations (e.g., talking to strangers, speaking in public, eating or drinking in front of others, or worrying about behaving in a shameful way).

Your doctor has considered that this medicine is suitable for treating your condition.

If you are not sure why you have been prescribed sertraline, you should consult your doctor.

2. What you need to know before you take Sertraline Cinfa

Do not take Sertraline Cinfa:

• If you are allergic to sertraline or any of the other ingredients of this medicine (listed in section 6).
• If you are taking or have taken in the last 14 days medicines called monoamine oxidase inhibitors (MAOIs, such as selegiline, moclobemide) or other medicines similar to MAOIs (such as linezolid). If you stop taking sertraline, you must wait at least one week before starting treatment with an MAOI. After stopping treatment with an MAOI, you must wait at least two weeks before starting treatment with sertraline.
• If you are taking another medicine called pimozide (a medicine used to treat mental disorders such as psychosis).

Warnings and precautions

Consult your doctor or pharmacist before starting to take sertraline.

Medicines are not always suitable for everyone. Before starting treatment with sertraline, tell your doctor if you have or have had any of the following:

• If you have epilepsy (seizures) or a history of seizures. If you have a seizure, contact your doctor immediately.
• If you have manic-depressive illness (bipolar disorder) or schizophrenia. If you have a manic episode, contact your doctor immediately.
• If you have or have had thoughts of harming yourself or suicidal thoughts (see below Suicidal thoughts and worsening of your depression or anxiety).
• If you have serotonin syndrome. This syndrome can occur rarely when taking certain medicines at the same time as sertraline. (To see the symptoms, read section 4. Possible side effects). Your doctor will tell you if you have had this syndrome before.
• If you have low sodium levels in your blood, as this condition may occur as a result of treatment with sertraline. You should also inform your doctor if you are taking any medication for hypertension, as these medications can also alter sodium levels in your blood.
• If you are elderly, as you may be at greater risk of having low sodium levels in your blood (see above).
• If you have liver disease; your doctor may consider that you should take a lower dose of sertraline.
• If you have diabetes; sertraline may alter your blood sugar levels, so it may be necessary to adjust the dose of your diabetes medications.
• If you have had bleeding disorders or have been taking medications that reduce blood clotting [such as acetylsalicylic acid (aspirin) or warfarin] or that may increase the risk of bleeding or if you are pregnant (see “Pregnancy, Breast-feeding and Fertility”).
• If you are a child or adolescent under 18 years of age. Sertraline should only be used to treat children and adolescents aged 6 to 17 years with obsessive-compulsive disorder (OCD). If you are going to be treated for this disorder, your doctor will want to monitor you closely (see below “Children and adolescents”).
• If you are receiving electroconvulsive therapy (ECT).
• If you have any eye disorder, such as certain types of glaucoma (increased intraocular pressure).
• If you have been told that you have an abnormality in the graph of your heart that is obtained after an electrocardiogram (ECG), known as prolongation of the QT interval.
• If you have heart disease, have low potassium or magnesium levels, family history of QT prolongation, low heart rate, or are taking concomitantly medications that prolong the QT interval.

Restlessness/Akathisia:

The use of sertraline has been associated with unpleasant restlessness and a need to move, often accompanied by an inability to remain seated or standing (akathisia). This occurs more often during the first few weeks of treatment. An increase in dose may be harmful, so if you develop these symptoms, you should contact your doctor.

Withdrawal symptoms:

Side effects related to discontinuation of treatment (withdrawal symptoms) are common, particularly if treatment is discontinued abruptly (see section 3. If you stop taking Sertraline Cinfa and section 4. Possible side effects). The risk of experiencing withdrawal symptoms depends on the duration of treatment, dose, and rate at which the dose is reduced. Generally, these symptoms are mild or moderate. However, in some patients, they can be severe. These symptoms usually occur during the first few days after treatment is discontinued. In general, these symptoms usually resolve on their own and normally disappear within two weeks. In some patients, they can last longer (2-3 months or more). It is recommended that when discontinuing treatment with sertraline, the dose should be gradually reduced over a period of several weeks or even months, and you should always agree with your doctor on the best way to discontinue treatment.

Suicidal thoughts and worsening of your depression or anxiety:

If you are depressed and/or have anxiety disorders, you may sometimes have thoughts of harming yourself or suicidal thoughts. This can increase at the beginning of treatment with antidepressants, due to the fact that all these medications take time to work, which is usually a few weeks but can sometimes be longer.

This is more likely to happen:

• If you have previously had suicidal thoughts or thoughts of harming yourself.
• If you are a young adult. There is information from clinical trials that shows that there is an increased risk of suicidal behavior in adults under 25 years of age with psychiatric disorders who are being treated with an antidepressant.

If you have thoughts of harming yourself or suicidal thoughts at any time, contact your doctor or go to the hospital immediately.

It may be helpful for you to explain to a family member or close friend that you are depressed or have an anxiety disorder and ask them to read this leaflet. You can also ask them to tell you if they think your depression or anxiety is getting worse, or if they are concerned about changes in your behavior.

Sexual problems

Some medicines in the same group as Sertraline Cinfa (called SSRIs) may cause symptoms of sexual dysfunction (see section 4). In some cases, these symptoms persist after treatment is discontinued.

Children and adolescents

Normally, sertraline should not be used in the treatment of children and adolescents under 18 years of age, except in the case of patients with obsessive-compulsive disorder (OCD). Patients under 18 years of age have a higher risk of side effects such as suicidal attempts, thoughts of harming themselves or suicidal thoughts (suicidal ideas), and hostility (mainly aggression, confrontational behavior, and anger) when they are being treated with this class of medications. However, your doctor may decide to prescribe sertraline to a patient under 18 years of age if they consider it to be in the patient's best interest. If your doctor has prescribed sertraline for you and you are under 18 years of age and wish to discuss this decision, please contact your doctor.

You should inform your doctor if any of the symptoms mentioned above appear or worsen while you are taking sertraline. Also, the long-term effects on safety and related to growth, maturity, and learning (cognitive development) and behavioral development of sertraline in this age group have not yet been established.

Taking Sertraline Cinfa with other medicines

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.

Some medicines can affect the way sertraline works, or sertraline itself may reduce the effectiveness of other medicines that you are taking at the same time.

Taking sertraline with the following medicines may cause serious side effects:

• Medicines called monoamine oxidase inhibitors (MAOIs, such as moclobemide for treating depression, selegiline for treating Parkinson's disease, the antibiotic linezolid, and methylene blue for treating high levels of methemoglobin in the blood). Do not take sertraline with these medicines.
• Medicines for treating mental disorders such as psychosis (pimozide). Do not take sertraline with pimozide.

Tell your doctor if you are taking the following medicines:

• Medicines containing amphetamines (used to treat attention deficit hyperactivity disorder (ADHD), narcolepsy, and obesity).
• Herbal medicines containing St. John's Wort (Hypericum perforatum). The effects of St. John's Wort may last 1-2 weeks.
• Products containing the amino acid tryptophan.
• Medicines for treating severe pain (e.g., tramadol).
• Medicines used in anesthesia or for treating chronic pain (e.g., fentanyl, mivacurium, and suxamethonium).
• Medicines for treating migraines (e.g., sumatriptan).
• Medicines that reduce blood clotting (warfarin).
• Medicines for treating pain/arthritis [non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, acetylsalicylic acid (aspirin)].
• Sedatives (diazepam).
• Diuretics.
• Medicines for treating epilepsy (phenytoin, phenobarbital, carbamazepine).
• Medicines for treating diabetes (tolbutamide).
• Medicines for treating acidity, ulcers, and heartburn (cimetidine, omeprazole, lansoprazole, pantoprazole, rabeprazol).
• Medicines for treating mania and depression (lithium).
• Other medicines for treating depression (such as amitriptyline, nortriptyline, nefazodone, fluoxetine, fluvoxamine).
• Medicines for treating schizophrenia and other mental disorders (such as perphenazine, levomepromazine, and olanzapine).
• Medicines for treating high blood pressure, chest pain, or for regulating heart rate and rhythm (such as verapamil, diltiazem, flecainide, propafenone).
• Medicines used to treat bacterial infections (such as rifampicin, clarithromycin, telithromycin, erythromycin).
• Medicines used to treat fungal infections (such as ketoconazole, itraconazole, posaconazole, voriconazole, fluconazole).
• Medicines used to treat HIV/AIDS and hepatitis C (protease inhibitors such as ritonavir, telaprevir).
• Medicines used to prevent nausea and vomiting after surgery or chemotherapy (aprepitant).
• Medicines known to increase the risk of changes in heart electrical activity (e.g., some antipsychotics and antibiotics).
• A medicine used to treat pain and fever (metamizol).

Taking Sertraline Cinfa with food, drinks, and alcohol

Sertraline tablets can be taken with or without food.

Alcohol consumption should be avoided while being treated with sertraline.

Sertraline should not be taken in combination with grapefruit juice, as it can increase sertraline levels in your body.

Pregnancy, breast-feeding, and fertility

If you are pregnant or breast-feeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

The safety of sertraline in pregnant women has not been fully established. If you are pregnant, sertraline will only be given to you if your doctor considers that the benefit to you outweighs any possible risk to the developing baby.

Make sure your midwife and/or doctor know that you are taking sertraline. If you take it during pregnancy, especially during the last 3 months, medicines like sertraline may increase the risk of a serious condition in babies called persistent pulmonary hypertension of the newborn (PPHN), which makes the baby breathe faster and have a bluish appearance. These symptoms usually start within the first 24 hours after birth. If this happens to your baby, contact your midwife and/or doctor immediately.

Your newborn baby may have other conditions, which usually appear within the first 24 hours after birth. The symptoms include:

• difficulty breathing,
• bluish skin or being too hot or cold,
• blue lips,
• vomiting or feeding problems,
• excessive tiredness, inability to sleep, or excessive crying,
• stiffness or decreased muscle tone,
• trembling, restlessness, or seizures,
• increased reflexes,
• irritability,
• low blood sugar levels.

If your baby has any of these symptoms at birth, or you are concerned about your baby's health, consult your doctor or midwife for advice.

If you take Sertraline Cinfa in the final stages of pregnancy, there may be an increased risk of heavy vaginal bleeding shortly after delivery, especially if you have a history of bleeding disorders. Your doctor or midwife should be aware that you are taking Sertraline Cinfa so that they can advise you.

There are indications that sertraline passes into breast milk. Therefore, sertraline can only be used in breast-feeding women if the doctor considers that the benefit to the mother outweighs any possible risk to the baby.

In animal studies, it has been seen that some medicines like sertraline may reduce sperm quality. Theoretically, this could affect fertility; however, the impact on human fertility has not yet been determined.

Driving and using machines

Psychotropic medicines like sertraline can affect your ability to drive or use machines. Therefore, do not drive or operate heavy machinery until you know how this medicine affects your ability to perform these activities.

Sertraline Cinfa contains lactose

This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.

3. How to take Sertralina cinfa

Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.

The recommended dose is:

Adults:

Depression and Obsessive-Compulsive Disorder:

For depression and OCD, the usually effective dose is 50 mg per day. The daily dose may be increased in increments of 50 mg, at intervals of at least one week, and so on for several weeks. The maximum recommended dose is 200 mg per day.

Anxiety Disorder, Social Anxiety Disorder, and Post-Traumatic Stress Disorder:

For anxiety disorder, social anxiety disorder, and post-traumatic stress disorder, treatment should be started with a dose of 25 mg per day, and increased to 50 mg per day after one week.

The daily dose may be increased in increments of 50 mg over a period of several weeks. The maximum recommended dose is 200 mg per day.

Use in children and adolescents:

Sertralina should only be used to treat children and adolescents aged 6 to 17 years who have OCD.

Obsessive-Compulsive Disorder:

Children from 6 to 12 years:The recommended starting dose is 25 mg per day. After one week, your doctor may increase the dose to 50 mg per day. The maximum dose is 200 mg per day.

Adolescents from 13 to 17 years:The recommended starting dose is 50 mg per day. The maximum dose is 200 mg per day.

If you have liver or kidney problems, inform your doctor and follow the instructions they indicate .

Method of administration:

Sertralina tablets can be taken with or without food.

Take your medication once a day, either in the morning or at night.

Your doctor will indicate the duration of treatment with this medication. The duration will depend on the nature of your illness and your response to treatment. It will take several weeks for your symptoms to start improving. Treatment of depression should normally continue for 6 months after improvement.

If you take more Sertralina cinfa than you should

If you accidentally take an excess of sertralina, contact your doctor or go to the emergency department of the nearest hospital. Always carry the medication package with you, whether there is medication left in it or not.

You can also call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.

The symptoms of overdose may include drowsiness, nausea and vomiting, rapid heart rate, tremors, agitation, dizziness, and rarely loss of consciousness.

If you forget to take Sertralina cinfa

Do not take a double dose to make up for forgotten doses. If you forget to take a dose, do not take it when you realize it. Take the next dose when it is due.

If you interrupt treatment with Sertralina cinfa

Do not interrupt treatment with sertralina unless your doctor indicates it. Your doctor will want to gradually reduce the dose of sertralina over several weeks before you stop taking this medication altogether. If you interrupt treatment abruptly, you may experience adverse effects such as dizziness, numbness, sleep disturbances, agitation or anxiety, headaches, nausea, vomiting, and tremors. If you experience any of these adverse effects, or any other during the interruption of your treatment with sertralina, please inform your doctor.

If you have any other doubts about the use of this medication, ask your doctor or pharmacist.

4. Possible adverse effects

Like all medications, this medication can produce adverse effects, although not all people suffer from them.

The most common adverse effect is nausea. Adverse effects depend on the dose and often disappear or decrease with continued treatment.

Inform your doctor immediately:

If you experience any of the following symptoms after taking this medication, as these symptoms can be serious.

• If you develop a severe skin rash that causes blisters (erythema multiforme), (can affect the mouth and tongue). These can be signs of a disease known as Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis (TEN). In these cases, your doctor will interrupt treatment.
• Allergic reaction or allergy, which can present symptoms such as skin rash with itching, breathing problems, wheezing, swelling of the eyelids, face, or lips.
• If you present agitation, confusion, diarrhea, increased temperature and blood pressure, excessive sweating, and rapid pulse. These are symptoms of serotonin syndrome. In rare cases, this syndrome can occur when taking certain medications at the same time as sertralina. Your doctor may decide to interrupt treatment.
• If you present yellowish color of the skin and eyes, which can indicate liver damage.
• If you present depressive symptoms with ideas of self-harm or suicide (suicidal thoughts).
• If after starting treatment with sertralina, you begin to feel restless and are unable to sit or stand. You should inform your doctor if you start to feel restless.
• If you have a seizure (convulsions).
• If you have a manic episode (see section 2. Warnings and precautions).

The following adverse effects were observed in clinical trials in adults and after marketing.

Very common(may affect more than 1 in 10 patients):

Insomnia, dizziness, drowsiness, headache, diarrhea, feeling unwell, dry mouth, ejaculation problems, and fatigue.

Common(may affect up to 1 in 10 patients):

• cold (chest), sore throat, runny nose,
• loss of appetite, increased appetite,
• anxiety, depression, agitation, decreased libido, nervousness, feeling strange, nightmares, teeth grinding,
• tremors, muscle movement problems (such as constant movement, muscle tension, difficulty walking, and stiffness, spasms, and involuntary muscle movements)*, numbness and tingling, muscle tension, lack of concentration, abnormal taste,
• visual disturbances,
• ringing in the ears,
• palpitations,
• hot flashes,
• yawning,
• stomach upset, constipation, abdominal pain, vomiting, gas,
• increased sweating, rash,
• back pain, joint pain, muscle pain,
• irregular menstrual cycle, erectile dysfunction,
• malaise, chest pain, weakness, fever,
• weight gain,
• injury.

Uncommon(may affect up to 1 in 100 patients):

• gastroenteritis, ear infection,
• tumor,
• hypersensitivity, seasonal allergy,
• low thyroid hormone levels,
• suicidal thoughts, suicidal behavior*, psychotic disorders, abnormal thoughts, lack of care, hallucinations, aggression, excessive happiness, paranoia,
• amnesia, decreased sensitivity, involuntary muscle contractions, fainting, continuous movement, migraine, convulsions, dizziness when standing up, abnormal coordination, speech disorders,
• dilated pupils,
• ear pain,
• rapid pulse, heart problems,
• bleeding problems (such as stomach bleeding)*, high blood pressure, hot flashes, blood in urine,
• shortness of breath, nosebleeds, difficulty breathing possibly noisy,
• black stools, tooth disorders, esophagus inflammation, tongue problems, hemorrhoids, increased salivation, difficulty swallowing, belching, tongue disorders,
• eye swelling, hives, hair loss, itching, purple spots on the skin, skin problems with blisters, dry skin, facial swelling, cold sweat,
• arthritis, muscle spasms, muscle cramps*, muscle weakness,
• increased urination frequency, urinary disorders, urinary retention, incontinence, increased urine volume, need to urinate at night,
• sexual dysfunction, excessive vaginal bleeding, vaginal hemorrhage, female sexual dysfunction,
• swollen legs, chills, difficulty walking, thirst,
• increased liver enzyme levels, weight loss,
• There have been reports of suicidal thoughts and behavior during treatment with sertralina or shortly after its interruption (see section 2).

Rare(may affect up to 1 in 1,000 patients):

• diverticulitis, lymph node swelling, decreased platelet count*, decreased white blood cell count*,
• severe allergic reaction,
• endocrine problems*,
• high cholesterol, problems controlling blood sugar levels (diabetes), low blood sugar, high blood sugar*, low sodium levels in blood*,
• physical symptoms due to stress or emotions, abnormal nightmares*, drug dependence, sleepwalking, premature ejaculation,
• coma, abnormal movements, movement difficulties, increased sensitivity, severe headache (which can be a sign of a serious disease known as reversible cerebral vasoconstriction syndrome (RCVS))*, sensory disturbances,
• vision problems, glaucoma, double vision, photophobia (eye sensitivity to light), eye bleeding, irregular pupils*, visual disturbances*, lacrimal problems, heart attack, dizziness, fainting or chest discomfort that may be signs of changes in heart activity (seen on an electrocardiogram) or abnormal heart rhythm*, decreased heart rate,
• circulation problems in arms and legs,
• rapid breathing, progressive scarring of lung tissue (interstitial lung disease)*, throat spasm, difficulty speaking, slow breathing, hiccups,
• mouth ulcers, pancreatitis*, blood in stools, tongue ulcers, mouth sores,
• liver function problems, severe liver function problems*, yellowish skin and eyes (jaundice)*,
• sunburn*, skin swelling*, abnormal hair texture, abnormal skin odor, capillary rash,
• muscle rupture*, bone disorder,
• urination problems, decreased urine volume,
• breast secretion, vaginal dryness, genital secretion, penile and foreskin pain and redness, breast enlargement*, prolonged erection,
• hernia, decreased drug tolerance,
• increased cholesterol levels, abnormal laboratory tests*, abnormal semen, coagulation problems*,
• relaxation of blood vessel procedure.

Frequency not known: cannot be estimated from available data:

• jaw locking*,
• nocturnal urinary incontinence*,
• partial loss of vision,,
• colon inflammation (which causes diarrhea)
• abundant vaginal bleeding shortly after childbirth (postpartum hemorrhage), see "Pregnancy, lactation, and fertility" in section 2 for more information.
• muscle weakness and severe muscle pain, which can be a sign of multiple acyl-CoA dehydrogenase deficiency (MADD).

*Adverse effects reported after marketing.

Other adverse effects in children and adolescents

In clinical trials in children and adolescents, adverse effects were generally similar to those reported in adults (see above). The most common adverse effects in children and adolescents were headache, insomnia, diarrhea, and nausea.

Symptoms that may appear when treatment is interrupted

If you interrupt treatment with this medication abruptly, you may experience adverse effects such as dizziness, numbness, sleep disturbances, agitation or anxiety, headaches, nausea, vomiting, and tremors (see section 3. If you interrupt treatment with Sertralina cinfa).

An increased risk of bone fractures has been observed in patients taking this type of medication.

Reporting of adverse effects

If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect that does not appear in this leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.

5. Conservation of Sertralina cinfa

Keep this medication out of sight and reach of children.

Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.

This medication does not require special storage conditions.

Medications should not be thrown away through wastewater or household waste. Ask your pharmacist how to dispose of packaging and medications that are no longer needed. This will help protect the environment.

6. Package contents and additional information

Sertralina cinfa composition

Each film-coated tablet contains sertralina hydrochloride equivalent to 150 mg of sertralina.

Each film-coated tablet contains sertralina hydrochloride equivalent to 200 mg of sertralina.

The other components in sertralina 150 mg tablets are: anhydrous colloidal silica, microcrystalline cellulose, sodium croscarmellose, copovidone, lactose monohydrate, stearic acid, magnesium stearate, hypromellose 2910, titanium dioxide, macrogol.

The other components in sertralina 200 mg are: anhydrous colloidal silica, microcrystalline cellulose, sodium croscarmellose, copovidone, lactose monohydrate, stearic acid, magnesium stearate, hypromellose 2910, titanium dioxide, macrogol, yellow iron oxide.

Product appearance and package contents

Sertralina 150 mg film-coated tablets are oblong and biconvex, white or almost white, 13 x 6 mm.

Sertralina 200 mg film-coated tablets are oblong and biconvex, yellow, 17 x 7 mm.

Sertralina film-coated tablets are available in aluminum/PVC/PVDC blisters containing 15, 30, and 60 tablets.

Only some package sizes may be marketed.

Marketing authorization holder and manufacturer

Marketing authorization holder:

Laboratorios Cinfa, S.A.

Carretera Olaz-Chipi, 10. Polígono Industrial Areta

31620 Huarte (Navarra) – Spain

Manufacturer:

Ferrer Internacional, S.A

Joan Buscallà 1-9

08173 Sant Cugat del Vallès

Spain

This medication is authorized in the member states of the European Economic Area, with the following names:

Date of the last revision of this leaflet:August 2025

Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

You can access detailed and updated information on this medication by scanning the QR code included in the leaflet and packaging with your smartphone. You can also access this information at the following internet address:

https://cima.aemps.es/cima/dochtml/p/84732/P_84732.html

https://cima.aemps.es/cima/dochtml/p/84733/P_84733.html

QR code to: https://cima.aemps.es/cima/dochtml/p/84732/P_84732.html

QR code to: https://cima.aemps.es/cima/dochtml/p/84733/P_84733.html